Examkin

Question

Difficulty: Very hardGynecologic Oncology

A 6464-year-old woman, G2P2, comes to the office due to a 33-month history of intermittent vaginal bleeding and new-onset breast fullness. Menopause occurred at age 5252. She has no other medical conditions and takes no medications. Vital signs are within normal limits. Pelvic examination reveals a normal-appearing vagina and cervix. Bimanual examination demonstrates a mobile, 88-cm, solid mass in the right adnexa and a globally enlarged, soft uterus. Transvaginal ultrasonography shows an 88-cm right ovarian mass with solid and cystic components, and an endometrial stripe thickness of 1414 mm. Which of the following is the most appropriate next step in management?

  1. A
    Measurement of serum CA-125 and inhibin levels
  2. B
    Exploratory laparotomy and surgical staging
  3. Endometrial biopsyAnswer
  4. D
    Hysteroscopy with dilatation and curettage
  5. E
    Magnetic resonance imaging of the pelvis

Answer

Endometrial biopsy
The correct next best step is an office endometrial biopsy. This patient presents with classic signs of hyperestrogenism: postmenopausal bleeding, breast fullness, a thickened endometrial stripe (1414 mm), and a solid/cystic adnexal mass. This presentation is highly suspicious for a granulosa cell tumor, an estrogen-secreting sex cord-stromal ovarian neoplasm. Chronic, unopposed estrogen exposure frequently leads to concurrent endometrial hyperplasia (up to 50%50\% of cases) or endometrial adenocarcinoma (5%5\% to 10%10\% of cases). While the ovarian mass will ultimately require surgical excision and staging, the immediate priority is to obtain a tissue diagnosis of the endometrium. If concurrent endometrial cancer is identified, the planned surgical procedure must be expanded to include complete staging for both malignancies (e.g., pelvic and para-aortic lymphadenectomy), which might not be routinely performed for an isolated presumed early-stage granulosa cell tumor. Therefore, histologic evaluation via a simple, minimally invasive office endometrial biopsy must precede definitive surgery.

Step-by-Step Solution

1
Identify the primary clinical abnormalities from the vignette.
The patient has postmenopausal bleeding (PMB), new breast fullness, an 88-cm complex adnexal mass, and a significantly thickened endometrium (1414 mm).
Recognizing these key findings is necessary to formulate a differential diagnosis and management plan.
2
Synthesize the findings to suspect a specific underlying pathology.
The combination of an adnexal mass, PMB, breast fullness, and endometrial thickening strongly points to a hormonally active tumor, specifically an estrogen-secreting granulosa cell tumor of the ovary.
Unregulated estrogen stimulation causes endometrial proliferation, leading to hyperplasia or carcinoma, and breast tenderness.
3
Determine the priority of management algorithms.
Although the adnexal mass requires surgical removal, the PMB with an endometrial stripe >4>4 mm mandates an immediate histologic evaluation of the endometrium.
Preoperative knowledge of endometrial pathology (hyperplasia vs. carcinoma) is essential, as the presence of endometrial cancer requires a more extensive surgical staging procedure (e.g., lymph node dissection) than the ovarian mass alone might dictate.
4
Select the most appropriate initial diagnostic modality.
An office endometrial biopsy is the highly sensitive, cost-effective, and minimally invasive first step.
It avoids unnecessary immediate operative procedures like D&C while providing the necessary tissue diagnosis.

Key Concept

Evaluation of postmenopausal bleeding in the setting of a suspected estrogen-secreting adnexal mass
Rate this question

Topics

Gynecologic Oncology

More questions from this topic